BIIB

Biogen Inc. · Healthcare · Drug Manufacturers - General
$178.96
+2.60 (+1.47%)
Mkt Cap: 26.26B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield7.9%
Dividend YieldN/A
Market Cap26.26B
Volume1.55M
Recent News
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
zacks.com · 2026-04-14
Why Biogen (BIIB) Could Beat Earnings Estimates Again
zacks.com · 2026-04-07
Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy's AntiClastic™ ASO Platform
businesswire.com · 2026-04-07
Why Biogen Stock Got Mashed on Monday
fool.com · 2026-04-06
Pharma, Biotech Giants Ramp Up M&A in Q1 to Boost Pipelines
zacks.com · 2026-04-06
15,051 Shares in Biogen Inc. $BIIB Bought by Element Squared LLC
defenseworld.net · 2026-04-04

Unlock the Full Deep Scan

9 AI agents analyze BIIB across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →